Joined-up health policy-making at the EU level is essential for improving the quality of cancer care, driving the development of innovative treatments, and addressing the medical needs of patients with cancer.
Αρχική World News ESMO Calls for Further EU Measures Enhancing Europe’s Clinical Trial Regulatory Ecosystem...
